Global Automated Needle Targeting (ANT) Market Growth 2024-2030

Global Automated Needle Targeting (ANT) Market Growth 2024-2030

According to our LPI (LP Information) latest study, the global Automated Needle Targeting (ANT) market size was valued at US$ 2286.6 million in 2023. With growing demand in downstream market, the Automated Needle Targeting (ANT) is forecast to a readjusted size of US$ 3460.9 million by 2030 with a CAGR of 6.1% during review period.

The research report highlights the growth potential of the global Automated Needle Targeting (ANT) market. Automated Needle Targeting (ANT) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Automated Needle Targeting (ANT). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Automated Needle Targeting (ANT) market.

ANT analyzes the X-ray or CT images, generates 2D (X-ray) or 3D (CT) models, and the puncture path was automatically calculated and transformed to motion parameters for the puncture robot through the artificial intelligence (AI) algorithms, thereby assisting doctors with accurate biopsies.

Increasing demand for minimally invasive procedures: Minimally invasive procedures offer advantages such as shorter hospital stays, faster recovery times, and reduced complications. ANT systems enable healthcare providers to perform these procedures with greater precision, making them more attractive to both patients and healthcare professionals.

Technological advancements: ANT systems continue to benefit from advancements in imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). These technologies provide real-time, high-resolution imaging, allowing for more accurate needle targeting and placement.

Rising prevalence of chronic diseases: The growing prevalence of chronic diseases like cancer and cardiovascular disorders has led to an increased demand for diagnostic and therapeutic procedures. ANT systems can aid in the precise targeting of tumors, lesions, and other affected areas, improving the effectiveness of treatments.

Improved patient outcomes: The use of ANT systems can reduce the risk of complications associated with needle-based procedures, such as organ damage or bleeding. By improving accuracy and reducing errors, these systems contribute to better patient outcomes and overall satisfaction.

Key Features:

The report on Automated Needle Targeting (ANT) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Automated Needle Targeting (ANT) market. It may include historical data, market segmentation by Type (e.g., Percutaneous Lung Biopsy, Percutaneous Nephrolithotomy), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Automated Needle Targeting (ANT) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Automated Needle Targeting (ANT) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Automated Needle Targeting (ANT) industry. This include advancements in Automated Needle Targeting (ANT) technology, Automated Needle Targeting (ANT) new entrants, Automated Needle Targeting (ANT) new investment, and other innovations that are shaping the future of Automated Needle Targeting (ANT).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Automated Needle Targeting (ANT) market. It includes factors influencing customer ' purchasing decisions, preferences for Automated Needle Targeting (ANT) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Automated Needle Targeting (ANT) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Automated Needle Targeting (ANT) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Automated Needle Targeting (ANT) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Automated Needle Targeting (ANT) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Automated Needle Targeting (ANT) market.

Market Segmentation:

Automated Needle Targeting (ANT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
Percutaneous Lung Biopsy
Percutaneous Nephrolithotomy

Segmentation by application
Hospitals
Ambulatory Surgical Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automated Needle Targeting (ANT) market?

What factors are driving Automated Needle Targeting (ANT) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automated Needle Targeting (ANT) market opportunities vary by end market size?

How does Automated Needle Targeting (ANT) break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.